Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR

Hardy Diagnostics

Orcutt, CA, US

HARDY DIAGNOSTICS appears in FDA device records in Orcutt, CA. FDA records list 109 510(k) clearances between and , no PMA records and 2 registered establishments. As of , FDA records show 24 recalls for this company, and at least one establishment registration is current.

FDA records held for this company

510(k) clearances
109
PMA records
0
Recall records
24
Registered establishments
2

FDA records under these names

1 name

FDA records resolved to Hardy Diagnostics carry these names as well, as FDA wrote them. Each is the firm named on a registration, a 510(k), a PMA, a recall or an enforcement report that was joined to this company on a shared FDA identifier or on a matching name.

  • Hardy Media Inc Dba Hardy Diagrecall

510(k) clearance history

Showing 50 of 109

FDA records hold 109 510(k) clearances for Hardy Diagnostics between 1993 and 2026. The busiest year on record is 2000, with 49. The most recent is 2026, with 1.

Clearances by year, as a table
510(k) clearance decisions for Hardy Diagnostics, by decision year
YearClearances
199312
19941
19951
19964
19971
19993
200049
20019
20061
20081
20102
20111
20152
20161
20175
20183
20194
20201
20232
20242
20253
20261
510(k) clearances on record, most recent first
K numberDeviceProduct codeDecisionDecision date
K260842HardyDisk AST Gepotidacin 10µg (GEP10)JTNSubstantially Equivalent
K253105HardyDisk AST Cefiderocol 30µg (FDC30)JTNSubstantially Equivalent
K250956HardyDisk AST Gepotidacin 10µg (GEP10)JTNSubstantially Equivalent
K250454HardyDisk Aztreonam/Avibactam 30/20µg (AZA50)JTNSubstantially Equivalent
K233534Viral Transport MediumJSMSubstantially Equivalent
K241060HardyDisk AST Cefiderocol 30µg (FDC30)JTNSubstantially Equivalent
K231568HardyDisk AST Sulbactam/Durlobactam 10/10µg (SUD20)JTNSubstantially Equivalent
K230827HardyDisk AST Rezafungin 5µg (RZF5)JTNSubstantially Equivalent
K193504HardyDisk AST Cefiderocol 30ug (FDC30)JTNSubstantially Equivalent
K192326HardyDisk AST Lefamulin 20µg (LMU20)JTNSubstantially Equivalent
K191931HardyDisk AST Imipenem/relebactam 10/25µg (IMR10/25)JTNSubstantially Equivalent
K190553HardyCHROM CREJSOSubstantially Equivalent
K183298HardyDisk AST Omadacycline 30µg (OMC30)JTNSubstantially Equivalent
K182357HardyDisk AST Eravacycline 20µg (ERV20)JTNSubstantially Equivalent
K181700HardyDisk AST Plazomicin 30ug (PLZ30)JTNSubstantially Equivalent
K173903Granada MediumPQZSubstantially Equivalent
K172621HardyDisk Meropenem/Vaborbactam 20/10µg (MEV30)JTNSubstantially Equivalent
K171975HardyDisk AST Delafloxacin 5 µg (DLX5)JTNSubstantially Equivalent
K170586Strep B Carrot Broth One-StepPQZSubstantially Equivalent
K170481Strep B Carrot Broth KitPQZSubstantially Equivalent
K170127HardyDisk Ceftolozane/Tazobactam, (30/10 ug)-C/T40JTNSubstantially Equivalent
K160512HardyCHROM ESBLJSOSubstantially Equivalent
K152846HardyDisk AST Ceftolozane/Tazobactam, (30/10ug)- C/T40JTNSubstantially Equivalent
K152838HardyDisk AST Ceftazidime/Avibactam, (30/20ug)-CZA50JTNSubstantially Equivalent
K102922HARDYCHROM MRSAJSOSubstantially Equivalent
K103538HARDYDISK AST CEFTAROLINE, 30 UG MODEL Z939JTNSubstantially Equivalent
K093807HARDYDISK AST TELAVANCIN,30UGJTNSubstantially Equivalent
K080019HARDYDISK AST DORIPENEM 10 UGJTNSubstantially Equivalent
K062245HARDY DISK AST TIGECYCLINE 15 UG, MODELZ936JTNSubstantially Equivalent
K011384HARDYDISK NOVOBIOCIN, 30MCG, MODEL Z883JTNSubstantially Equivalent
K011385HARDKYDISK NEOMYCIN, 30 MCGJTNSubstantially Equivalent
K011086HARDYDISK BACITRACIN, 10MCG, MODEL Z927JTNSubstantially Equivalent
K003690HARDYDISK SULFISOXAZOLEJTNSubstantially Equivalent
K003554HARDYDISK TRIMETHOPRIM 5MCGJTNSubstantially Equivalent
K003556HARDYDISK AMOXICILLIN/CLAVULANIC ACID, 20/10MCGJTNSubstantially Equivalent
K003686HARDYDISK TICARCILLIN/CLAVULANIC ACID, 85MCGJTNSubstantially Equivalent
K003537HARDYDISK RIFAMPIN, 5MCGJTNSubstantially Equivalent
K003536HARDYDISK NAFCILLIN, 1 MCGJTNSubstantially Equivalent
K003532HARDY DISK, CEFPODOXINE, 10MCGJTNSubstantially Equivalent
K002662HARDYDISK CLINDAMYCIN, 2MCGJTNSubstantially Equivalent
K002664HARDYDISK LEVOFLOXACIN, 5MCGJTNSubstantially Equivalent
K002661HARDYDISK CEFOTETAN, 30MCGJTNSubstantially Equivalent
K002660HARDYDISK LOMEFLOXACIN, 10MCGJTNSubstantially Equivalent
K002369HARDYDISK GENTAMICIN, 120MCGJTNSubstantially Equivalent
K002367HARDY DISK CEFTIZOXIME, 30MCGJTNSubstantially Equivalent
K002656HARDYDISK CEFUROXIME, 30MCGJTNSubstantially Equivalent
K002368HARDYDISK STREPTOMYCIN, 300MCGJTNSubstantially Equivalent
K002663HARDYDISK NETILMICIN, 30MCGJTNSubstantially Equivalent
K001728HARDY DISK CLARITHROMYCIN, 15MCGJTNSubstantially Equivalent
K001487HARDYDISK CINOXACIN, 100 MCGJTNSubstantially Equivalent

Registered establishments

FDA registered establishments for Hardy Diagnostics, with the product codes listed at each
RegistrationFEIEstablishmentAddressRegistration expiresProduct codes listed
20228072022807HARDY DIAGNOSTICS1430 WEST MCCOY LN., Orcutt, CA 93455 US2026and 22 more, listed in full below
30095479543009547954Hardy Diagnostics429 S Pioneer Blvd, Springboro, OH 45066 US2026and 11 more, listed in full below

Registration numbers link to the FDA registration and listing record for that establishment.

FDA product codes

Recall records

Device recall records naming this company, most recent first
RecallProductReasonClassificationInitiatedStatus
Z-2887-2026HardyDisk AST Cefiderocol 30g (FDC30) REF Z9435 HardyDisk AST Cefiderocol 30g (FDC30) for in vitro agar diffusion susceptibility testing is indicated when there is the need to determine the susceptibility of Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii complex and Stenotrophomonas maltophilia to Cefiderocol,Due to incorrect cartridges include in affected products that there is the potential for false-susceptible or false-resistant susceptibility results and may lead to selection of an ineffective antimicrobial therapy, potentially resulting in delayed appropriate treatment, prolonged infection, or worsening clinical outcome.Class IIOpen, Classified
Z-2041-2025HardyCHROM CRE, selective and differential culture medium for antimicrobial susceptibility testing, Product Catalog No. G323Identified lots failed incoming quality control testing. Lots exhibited breakthrough growth of Klebsiella pneumoniae.Class IIOpen, Classified
Z-1835-2021Quickslide GramPro 1 Automated Gram Stanier is a microscope slide stainer.Instruments were assembled and serviced using a defective lot of tubing, which is part of the pump mechanism within the unit.Class IITerminated
Z-0919-2021Brain Heart Infusion Agar with 6 ug/ml Vancomycin Cat no: G14 Lot no: 472698 Manufactured: 2020-10-29 Expires: 2020-12-28 Container Type: 15x100mm plate, 18 mlComplaints were received reporting of Staphylococcus aureus (ATCC 29213) breakthrough when the strain should have been inhibited.Class IITerminated
Z-0655-2021Viral Transport Medium, 3ml, Ref: R99, Container type: Tube, Packaged: 20 tubes/box, IVD, CVM Transport Media is provided in plastic centrifuge tubes and is used for the collection and transport of clinical specimens for the recovery of viral agentsThere is a potential for contamination within Viral Transport Media. Use of contaminated Viral Transport Media for the transport of patient specimen may compromise the detection of COVID-19 by the final device used for testing.Class IITerminated
Z-0441-2021Strep B Carrot Broth One-Step, Ref. Z40, UDI: 00819398026499Streptococcus culture medium contains an incorrect expiration date. The culture medium outer box labeling contains an expiration date of 2021-11-10 instead of the correct expiration date of 2020-11-10Class IIITerminated
Z-2298-2020HardyCHROM MRSA,REF; G307, LOT: 447694, A selective and differential chromogenic medium for the qualitative direct detection of nasal colonization by methicillin-resistant Staphylococcus aureus (MRSA). Not intended to diagnose infection of guide therapy. Further testing required for susceptibility or typing. Container Type: 15 x 100mm monoplate Packaged: 10 plates/sleeve STORAGE: 2-8 degree C on receipt, LIGHT SENSITIVE IVD UDI: (01)08165760201400 (10)447694 (17)191206False Positive results due to the MSSA (methicillin-susceptible) strain Staphylococcus aureus (ATCC 29213) breakthrough when this strain should have been inhibited.Class IITerminated
Z-2146-2016QuickSlide MGS-80, Automated Mutli-Slide Gram Stainer/GramPRO-80. Systematically stains, rinses, decolorizes, and counter-stains the provided biological sample and slide.Discrepant culture and gram stain results, which could potentially lead to misdiagnosis or improper treatment of a patient.Class IITerminated
Z-1571-2016Hardy Diagnostics GBS Detect Cat no. A300. Used for the isolation and detection by enhanced hemolysis of gamma-hemolytic (non-hemolytic) Group B Streptococcus.Performance failure; poor hemolytic reaction of non or weakly hemolytic group B streptococcus (GBS) with the target QC organism, Streptococcus agalactiae (ATCC 13813) due to product deterioration.Class IITerminated
Z-0470-2016FB Broth, 10ml (Fastidious Bacteria Broth) Cat. no: K31 Lot: 15231 A fastidious bacteria broth for the enriched cultivation of Neisseria spp., Haemophilus spp., Streptococcus spp., Corynebacterium spp., and other fastidious bacteria from clinical specimens.The firm is recalling FB Broth Cat. no. K31, Lot no. 15231 because of potential Burkholderia fungorum contamination.Class IITerminated
Z-2463-2015HardyCHROM MRSA Cat no: G307 Lot no: H15155 Expires: 2015-08-13 Container Type: 15x100mm monoplate Packaged: 10 plates/sleeve Storage: 2-8C on receipt. Light Sensitive. In vitro diagnostic www.HardyDiagnostics.comHardy Diagnostics is recalling HardyCHROm MRSA due to a report of the potential for breakthrough of the methicillin-sensitive Staphylococcus aureus (MSSA) QC strain, ATCC 29213 on the identified lot.Class IITerminated
Z-2279-2015Hardy Diagnostics VRE Broth, 5ml container type: 16x100mm tube packaged: 20 tubes/box fill: 5ml Product Usage: BEA (Bile Esculin Azide) Broth with Vancomycin is for the surveillance of vancomycin resistant enterococci (VRE) not to be used for susceptibility reporting.Hardy Diagnostics is recalling MacConkey Agar with Ciprofloxacin, Brain Heart Infusion Broth with Ciprofloxacin 1 ug, MDR Acinetobacter, BEA with Azide and Vancomycin, BEA Agar with Vancomycin, Gentamicin, and Amphotericin B, BEA Broth with Vancomycin, and VRE Broth due to lack of 510(k) clearance.Class IITerminated
Z-2278-2015Hardy Diagnostics BEA Broth with Vancomycin container type: 13x100mm tube packaged: 20 tubes/box fill: 2ml Product Usage: BEA (Bile Esculin Azide) Broth with Vancomycin is for the surveillance of vancomycin resistant enterococci (VRE) not to be used for susceptibility reportingHardy Diagnostics is recalling MacConkey Agar with Ciprofloxacin, Brain Heart Infusion Broth with Ciprofloxacin 1 ug, MDR Acinetobacter, BEA with Azide and Vancomycin, BEA Agar with Vancomycin, Gentamicin, and Amphotericin B, BEA Broth with Vancomycin, and VRE Broth due to lack of 510(k) clearance.Class IITerminated
Z-2277-2015Hardy Diagnostics BEA Agar with VGA container type: 15x100mm monoplate packaged: 10 places/sleeve Product Usage: BEA (Bile Esculin Azide) Agar with Vacomycin, Gentamicin, and Amphotericin B is for the selective isolation of vancomycin resistant enterococci (VRE).Hardy Diagnostics is recalling MacConkey Agar with Ciprofloxacin, Brain Heart Infusion Broth with Ciprofloxacin 1 ug, MDR Acinetobacter, BEA with Azide and Vancomycin, BEA Agar with Vancomycin, Gentamicin, and Amphotericin B, BEA Broth with Vancomycin, and VRE Broth due to lack of 510(k) clearance.Class IITerminated
Z-2276-2015Hardy Diagnostics BEA Agar with Vancomycin container type: 15x100mm monoplate packaged: 10 plates/sleeve Product Usage: BEA (Bile Esculin Agar) with Azide and Vancomycin for VRE is used as a direct screening medium in the isolation and presumptive identification of vancomycin-resistant enterococci/group D streptococci, such as Enterococcus faecalis and E. faecium, from fecal and rectal cultures.Hardy Diagnostics is recalling MacConkey Agar with Ciprofloxacin, Brain Heart Infusion Broth with Ciprofloxacin 1 ug, MDR Acinetobacter, BEA with Azide and Vancomycin, BEA Agar with Vancomycin, Gentamicin, and Amphotericin B, BEA Broth with Vancomycin, and VRE Broth due to lack of 510(k) clearance.Class IITerminated
Z-2275-2015Hardy Diagnostics MDR Acinetobacter container type: 15x100mm monoplate packaged: 10 plates/sleeve Product Usage: MDR Acinetobacter is for the primary selective screening for detection and differentiation of multi-drug resistant (MDR) Acinetobacter baumannii.Hardy Diagnostics is recalling MacConkey Agar with Ciprofloxacin, Brain Heart Infusion Broth with Ciprofloxacin 1 ug, MDR Acinetobacter, BEA with Azide and Vancomycin, BEA Agar with Vancomycin, Gentamicin, and Amphotericin B, BEA Broth with Vancomycin, and VRE Broth due to lack of 510(k) clearance.Class IITerminated
Z-2274-2015Hardy Diagnostics BHI with CIPRO, 1ug/ml container type: 16x100mm tube packaged: 20 tubes/box Product Usage: Brain Heart Infusion Broth with Ciprofloxacin, 1ug is for use as pre-enrichment broth for the cultivation of ciprofloxacin-resistant organisms from clinical samples.Hardy Diagnostics is recalling MacConkey Agar with Ciprofloxacin, Brain Heart Infusion Broth with Ciprofloxacin 1 ug, MDR Acinetobacter, BEA with Azide and Vancomycin, BEA Agar with Vancomycin, Gentamicin, and Amphotericin B, BEA Broth with Vancomycin, and VRE Broth due to lack of 510(k) clearance.Class IITerminated
Z-2273-2015Hardy Diagnostics MacConkey Agar with CiPRP, 1ug/ml Container type: 15x100mm monoplate packaged: 10 plates/sleeve Product Usage: MacConkey Agar with Ciprofloxacin is used as a screening medium for the selective isolation of Ciprofloxacin-resistant E. coli from clinical samples.Hardy Diagnostics is recalling MacConkey Agar with Ciprofloxacin, Brain Heart Infusion Broth with Ciprofloxacin 1 ug, MDR Acinetobacter, BEA with Azide and Vancomycin, BEA Agar with Vancomycin, Gentamicin, and Amphotericin B, BEA Broth with Vancomycin, and VRE Broth due to lack of 510(k) clearance.Class IITerminated
Z-2192-2015HardyCHROM VRE Agar-RSR Cat no: GA333 Lot no: H15055 Expires: 2015-07-04 Container type: 15x100mm monoplate Packaged: 10 plates/sleeve Storage 2 to 8 degrees C on receipt Chromogenic medium for stool pathogen screening.Hardy Diagnostics is recalling HardyCHROM VRE Agar due to lack of 510(k) clearance.Class IITerminated
Z-1444-2015Hardy Diagnostics cat no. G327 HardyCHROM SS Agar (HardyCHROM Salmonella Shigella) Cat no: G327 Container type: 15x100mm monoplate Packaged: 10 plates/sleeve Storage: 2 to 8 degrees C. on receipt in dark A selective chromogenic medium for the primary screening isolation, and differentiation of Salmonella & Shigella spp.The firm is recalling HardyCHROM SS, Cat. no. G327 Lot no. 15037 due to a report of possible lack of color development in Shigella organisms in the referenced lot.Class IITerminated
Z-0078-2007HardyCHROM 0157, Catalogue Number: G305, Lot Numbers: 06192 & 06235, Packaged: 10 plates per sleeve, Hardy Diagnostics, Santa Maria, CA 93455Performance failure; the product is failing to show pigment development for E. coli 0157.Terminated
Z-1451-06BHI Agar with Vancomycin, for in vitro diagnostic use. Catalog # G14, Lot# 06136This recall is being conducted due to the performance failure nearing the end of the product shelf life.Terminated
Z-0542-04Nitrate Reagent A, Cat No. Z71, Lot 3338 Nitrate Reagent B, Cat No. A72, Lot 3338Mislabeled.Terminated
Z-1076-03Blood Agar Plates, 5%, Lot 3155A.Customers complained of bacterial contamination of lot A10-3155A.Terminated

Verification record

There is no verification record for this company. Most companies on this site have none: a record exists only where a company asked to be verified and MDM ran the checks, so the absence of one says nothing about the company.

Where there is a record, this is where it appears: what was checked, when it was checked, and the current status. An MDM Verified badge on another website links to a verify address on this domain that resolves to this section. A badge that does not resolve here is not ours.

What MDM checks, and what it does not

MDM coverage

MDM coverage of this company lists here, newest first. Submit news.

Is this your company?

This page is built from public FDA records. Company pages are free and factual, and stay free whether or not anyone claims them. Membership never changes editorial coverage or vetting outcomes.

Claiming lets Hardy Diagnostics edit what it says about itself and list the categories it works in. It grants no badge: claiming is not verification.

Claim this page

Data as of , FDA export datePage updated Source: openFDA, public domain